Dasatinib Invista 70mg Tablet

Get a Price/Quote

MOQ : 10 Pieces

Dasatinib Invista 70mg Tablet Specification

Life Span
As per expiry date indicated on pack.

Dosage Form
Tablet

Origin of Medicine
India

Brand Name
Invista

Packaging Type
Box / Blister pack

Pacakaging (Quantity Per Box)
Not clearly specified

Indication
Chronic Myeloid Leukemia (CML), Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Salt Composition
Dasatinib

Drug Type
Anti-cancer/Oncology

Ingredients
Dasatinib

Physical Form
Tablet

Function
Effective tyrosine kinase inhibitor for treating leukemia.

Recommended For
Adults with specific types of leukemia (CML, Ph+ ALL)

Dosage
As directed by the physician (commonly 70mg once daily)

Dosage Guidelines
Administer orally as prescribed by healthcare professional.

Suitable For
Adults

Quantity
Not specified (common packs 30 tablets)

Storage Instructions
Store below 30C. Keep away from moisture and light.

Strength
70mg

Administration Route
Oral

Marketed In
Canada, Europe, UK, USA, Australia (as indicated by flags on packaging)

Prescription Required
Yes

Therapeutic Class
Antineoplastic Agents

ATC Code
L01XE06

Dasatinib Invista 70mg Tablet About

Dasatinib Invista 70mg Tablet is an eminent and celebrated oral antineoplastic agent, designed to provide unmatchable benefits for adults diagnosed with Chronic Myeloid Leukemia (CML) or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL). Marked by savings through clearance opportunities, this prescription-only medication is trusted across Canada, Europe, UK, USA, and Australia. Each tablet, containing the potent tyrosine kinase inhibitor Dasatinib, ensures effective treatment as directed by your physician. Invista's reliability and global recognition make it a premier choice for oncology care.

How to Use & Competitive Advantage of Dasatinib Invista 70mg

Dasatinib Invista 70mg Tablets should be taken orally as prescribed by your healthcare provider, typically once daily. Its unmatchable efficacy stems from its role as a potent tyrosine kinase inhibitor, targeting leukemia cells with precision. Used in the treatment of CML and Ph+ ALL, Invista is celebrated for its consistent, doctor-directed dosing, and recognized among eminent oncology therapies. Ensure to follow all medical advice regarding timing, dosage, and storage for optimal therapeutic effect.

Sample Policy, Market & Packaging for Dasatinib Invista 70mg

Interested customers may benefit from sample policies allowing a drop-off of trial packs before purchase. Dasatinib Invista is offered at a competitive sale price and is available for transportation across major domestic markets, including rapid fulfillment in India and export to the USA, UK, Europe, Australia, and Canada. Packaged securely in box or blister pack formats, the packaging safeguards the product from moisture and light, ensuring safety and efficacy until the indicated expiry date.

FAQ's of Dasatinib Invista 70mg Tablet:

Q: How should Dasatinib Invista 70mg Tablets be administered?

A: Dasatinib Invista 70mg tablets are to be taken orally, once daily or as directed by your healthcare professional. Follow your physician's instructions carefully to ensure safe and effective use.

Q: What conditions are treated with Dasatinib Invista 70mg?

A: This medication is recommended for adults with Chronic Myeloid Leukemia (CML) or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL). It functions as a tyrosine kinase inhibitor to target cancerous cells.

Q: When can I expect to receive Dasatinib Invista after purchase?

A: Once purchased, Dasatinib Invista 70mg is dispatched for transportation promptly. Delivery timelines depend on your location, with expedited service available in major domestic and international markets.

Q: Where is Dasatinib Invista 70mg available for sale and distribution?

A: Dasatinib Invista 70mg is marketed and distributed in Canada, Europe, the UK, USA, Australia, and India, as indicated by its packaging. It is available through approved pharmaceutical suppliers and healthcare providers.

Q: What are the packaging details and storage requirements for Dasatinib Invista?

A: The tablets come in secure box or blister packs. Store them below 30C, away from moisture and light, to maintain effectiveness and safety up to the expiry date printed on the pack.

Q: What competitive advantages does Invista offer in leukemia treatment?

A: Invista's main advantages include celebrated global recognition, unmatchable efficacy as a potent antineoplastic agent, and trusted quality for prescribers and patients managing CML and Ph+ ALL.

Tell us about your requirement